Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma

BACKGROUND: Regulated in development and DNA damage response (REDD1), a gene responding to hypoxia or multiple DNA damage events, was recently implicated in cancer development and progression. Previously, in vivo and in vitro experiments indicated that REDD1 functions as an oncogene in ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Bin, Meng, Jiao, Zhu, Huimin, Du, Xiang, Sun, Lili, Wang, Lei, Li, Shugang, Yang, Gong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236897/
https://www.ncbi.nlm.nih.gov/pubmed/30428884
http://dx.doi.org/10.1186/s13000-018-0754-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236897/
https://www.ncbi.nlm.nih.gov/pubmed/30428884
http://dx.doi.org/10.1186/s13000-018-0754-4

Ejemplares similares